Clinical Trial Update: Bioequivalence of Rebamipide in Korean [NA]

View source ↗

Summary

The study completed an evaluation of bioequivalence for Rebamipide in Korean subjects, addressing therapeutic equivalence and pharmacogenetic considerations.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer
• Gastritis
• Peptic Ulcer Disease

Drugs mentioned

• Rebamipide (Mucosta) (rebamipide)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Therapeutic Equivalency, Pharmacogenetics | NA | Status: COMPLETED